Eisai's hhc Philosophy Investors Sustainability About Eisai News Release Japanese Worldwide Contact Us Certificate of Appreciation from National Department of Health of Papua New Guinea Eisai's Support towards COVID-19 News Release Latest News Information November 19, 2021 EISAI SELECTED FOR MEMBERSHIP IN DOW JONES SUSTAINABILITY ASIA PACIFIC INDEX 2021 FOR EIGHTH TIME November 18, 2021 EISAI RECEIVES THE “MOST LIKED!” IR AWARD AT THE 2021 IR AWARD November 17, 2021 Update on Regulatory Review of Aducanumab in the European Union November 12, 2021 New Phase 3 Data Show Positive Correlation Between ADUHELM™ Treatment Effect on Biomarkers and Reduction in Clinical Decline in Alzheimer’s Disease November 12, 2021 EISAI PRESENTS NEW ANALYSIS OF LECANEMAB CLINICAL EFFICACY RESULTS FROM PHASE 2B STUDY AT CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD) CONFERENCE Consistency of Efficacy Assessments Evaluated Across Various Statistical Methods View All Annual Financial Results for the Fiscal Year Ended March 31, 2021 Our Response to the Novel Coronavirus Infection Florence Nightingale Virtual Gallery #ThisIsMBC Elements Campaign Showcases Powerful Portraits of Patients Living with Metastatic Breast Cancer and Their Caregivers Sharing Their Journeys to Inspire Others About Eisai Message from Top Management Corporate Mission Corporate Information Corporate Governance Business Activities Video Library Compliance and Risk Management About Eisai TOP Eisai's hhc Philosophy What is hhc? Knowledge Creation Recent hhc Activities Eisai's hhc Philosophy TOP Investors Management Policy IR Library IR Events Stock & Bond Information Eisai at a Glance Investors TOP Sustainability 28 countries 2.02 billion tablets Number of countries supplied with lymphatic filariasis treatment and volume supplied (as of August 2021) Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries Sustainability Management Corporate Governance Relationship with Customers Relationship with Society Relationship with Our Employees Relationship with Business Partners Environmental Activities Sustainability TOP Improving Access to Medicines TOP Initiatives for Lymphatic Filariasis Other Access to Medicines Initiatives Infectious Diseases Research & Development Sitemap Privacy Policy Terms of Use SNS Community Guidelines Accessibility TwitterEisai official account Copyright © Eisai Co., Ltd. All Rights Reserved.